Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
2.760
+0.270 (10.84%)
At close: Jan 2, 2026, 4:00 PM EST
2.750
-0.010 (-0.36%)
After-hours: Jan 2, 2026, 7:56 PM EST
Acurx Pharmaceuticals Market Cap
Acurx Pharmaceuticals has a market cap or net worth of $5.76 million as of January 2, 2026. Its market cap has decreased by -58.70% in one year.
Market Cap
5.76M
Enterprise Value
-151.20K
1-Year Change
-58.70%
Ranking
Category
Stock Price
$2.76
Market Cap Chart
Since the IPO on June 25, 2021, Acurx Pharmaceuticals's market cap has decreased from $57.25M to $5.76M, a decrease of -89.95%. That is a compound annual growth rate of -39.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2026 | 5.76M | 10.84% |
| Dec 31, 2025 | 5.19M | -62.24% |
| Dec 31, 2024 | 13.75M | -73.92% |
| Dec 29, 2023 | 52.73M | 14.29% |
| Dec 30, 2022 | 46.14M | 4.51% |
| Dec 31, 2021 | 44.15M | -22.88% |
| Jun 25, 2021 | 57.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 957.59B |
| Johnson & Johnson | 497.06B |
| AbbVie | 404.38B |
| UnitedHealth Group | 303.43B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 262.03B |
| Novo Nordisk | 230.76B |